Ireland
--:--IST
Recruiting Not applicable

Nursing Care of Bipolar Patients With Sleeping Disorders Using Luminotherapy and /or Psychoeducation Program (BIPLUMINO)

NCT04917419 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2022-12-05
Last updated
2026-01-13

Condition(s) studied

Bipolar Disorder

Investigational drug(s) / intervention(s)

Luminotherapy and /or Psychoeducation Program

Luminotherapy and /or Psychoeducation Program: TO complete

Study summary

Bipolar disorder affects more than 1% of the population. This pathology is considered as one of the most serious psychiatric disorder because of it is high suicide rates. It impacts patients life quality on many aspects, and specially their sleeping and circadian Rhythms. This can lead to more severe symptoms up to for thymic relapses. It was shown that Luminotherapy and Psychoeducation Program have a positive impact on these type of symptoms.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Main inclusion Criteria: * Bipolar disorder (type 1 and 2 according to DSM V) * Mood Disorder Questionnaire MDQ ˂ 7 * Sleeping and Circadian Rhythms Disorders * Under treatment Main exclusion Criteria: * No addiction except for tobacco * Narcolepsy * Sleep Apnea * Psychiatric comorbidities * Suicidal ideation

Primary outcome measure(s)

  • Number of days in-hospital — Day 0 to Day 365
    Number of days patients spent in the hospital

Trial sites (1)

FacilityCityRegionStatus
Centre Hospitalier Henri Laborit Poitiers France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04917419 on ClinicalTrials.gov ↗ ← All trials in France